| ASG Stock | | | CAD 0.45 0.02 4.65% |
Founder
Mr. Laszlo Garamszegi is Chief Technology Officer of Aurora Spine Corp since 2014.
| Age | 53 |
| Tenure | 10 years |
| Address | 20 Holly Street, Toronto, ON, Canada, M4S 3B1 |
| Phone | 760 424 2004 |
| Web | https://www.aurora-spine.com |
Garamszegi brings over 10 years of executive experience in the medical device industry, most recently as the Chief Technology Officer of Phygen, LLC. He has a track record of cofunding and building several medical device companies, as well as developing those companies’ engineering, quality, regulatory and manufacturing departments from the ground up. He was awarded three U.S. patents related to his spinal implant designs, and has over 10 patents pending in the spinal arena. He is also the coinventor of the 4Closure Laparoscopic Fascia Closure Device used in Bariatric, OB/GYN, and general laparoscopic procedures; this technology was sold to Synovis Life Technologies in 2007, where it is currently marketed under the "LapAssist" brand name by Baxter.
Aurora Spine Management Efficiency
The company has return on total asset
(ROA) of
(0.025) % which means that it has lost $0.025 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.1452) %, meaning that it generated substantial loss on money invested by shareholders. Aurora Spine's management efficiency ratios could be used to measure how well Aurora Spine manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to -0.16 in 2024.
Return On Capital Employed is likely to drop to -0.05 in 2024. At this time, Aurora Spine's
Other Current Assets are fairly stable compared to the past year.
Intangibles To Total Assets is likely to climb to 0.1 in 2024, whereas
Non Current Assets Total are likely to drop slightly above 2.4
M in 2024.
Aurora Spine Corp has accumulated 3.65
M in total debt with debt to equity ratio
(D/E) of 92.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aurora Spine Corp has a current ratio of 2.42, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aurora Spine until it has trouble settling it off, either with new capital or with free cash flow. So, Aurora Spine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurora Spine Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurora to invest in growth at high rates of return. When we think about Aurora Spine's use of debt, we should always consider it together with cash and equity.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and commercialization of interspinous fusion systems and devices in Canada. The company was incorporated in 2013 and is headquartered in Toronto, Canada. AURORA SPINE operates under Medical Devices classification in Canada and is traded on TSX Venture Exchange. Aurora Spine Corp (ASG) is traded on TSX Venture Exchange in Canada and employs 5 people. Aurora Spine is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
Aurora Spine Corp Leadership Team
Elected by the shareholders, the Aurora Spine's board of directors comprises two types of representatives: Aurora Spine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurora. The board's role is to monitor Aurora Spine's management team and ensure that shareholders' interests are well served. Aurora Spine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurora Spine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Aurora Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aurora Spine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Aurora Stock Analysis
When running Aurora Spine's price analysis, check to
measure Aurora Spine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Spine is operating at the current time. Most of Aurora Spine's value examination focuses on studying past and present price action to
predict the probability of Aurora Spine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Spine's price. Additionally, you may evaluate how the addition of Aurora Spine to your portfolios can decrease your overall portfolio volatility.